| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |